About Nidus Pharma Private Limited
Data last updated:
Nidus Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 April 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239CH2004PTC041578. Its GSTIN is 04AABCN9364Q1ZU (Chandigarh). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.85 Lakh. It is led by directors including Sanjay Bansal and Alka Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nidus Pharma Private Limited Scf – 333 Second Floor Moter Market Monay, Mazara, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.5 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹37.36 Lakh (net margin 2.8%) and EBITDA of ₹68.24 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 18% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.14 Cr and satisfied charges of ₹4.85 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website niduspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNidus Pharma Private Limited Scf – 333 Second Floor Moter Market Monay, Mazara, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nidus Pharma Private Limited
The main business activity of Nidus Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nidus Pharma Private Limited FY 2025 filings available
Nidus Pharma Private Limited reported revenue of ₹13.5 Cr (up 49% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Nidus Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 49% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nidus Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹68.24 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹37.36 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nidus Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nidus Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nidus Pharma Private Limited
Nidus Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Its own revenue is ₹13.5 Cr.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rouzel Pharma Private Limited | ₹13.56 Cr | •••• | •••• | •••• | - | Manimajra, Chandigarh, India |
| Caplet Health Care Private Limited | ₹13.53 Cr | •••• | •••• | •••• | 49 | Kolkata, West Bengal, India |
| Menrik Biomerge Private Limited | ₹13.52 Cr | •••• | •••• | •••• | - | Shahdara, Delhi, India |
| Dhwanilife Care Private Limited | ₹13.5 Cr | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Avancer Labs Private Limited | ₹13.5 Cr | •••• | •••• | •••• | 22 | New Dlehi, Delhi, India |
| Nidus Pharma Private Limited this company | ₹13.5 Cr | •••• | •••• | •••• | - | Chandigarh, India |
| Healthnovo Digilife Private Limited | ₹13.49 Cr | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| KNM Pharma Private Limited | ₹13.41 Cr | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Stanwell Lifesciences Private Limited | ₹13.39 Cr | •••• | •••• | •••• | 102 | New Delhi, Delhi, India |
| Seagull Laboratories (India) Private Limited | ₹13.38 Cr | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Southern Union Pharmaceuticals Kerala Private Limited | ₹13.37 Cr | •••• | •••• | •••• | 44 | Thrissur, Kerala, India |
Peers are the five companies nearest above and the five nearest below Nidus Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and growth of each peer are in the company report.
Auditor Details of Nidus Pharma Private Limited
Nidus Pharma Private Limited is audited by NEERAJ CHAWLA & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NEERAJ CHAWLA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nidus Pharma Private Limited
Nidus Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Bansal | Director | 10 Mar 2015 | 11 Years 6 Months | Current |
| Alka Bansal | Director | 03 Oct 2025 | 1 Years 0 Months | Current |
| Prakhar Bansal | Director | 03 Oct 2025 | 1 Years 0 Months | Current |
| Krati Bansal | Director | 03 Oct 2025 | 1 Years 0 Months | Current |
Ownership and Shareholding of Nidus Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nidus Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2025 | Axis Bank Limited | ₹9 Cr | Open |
| 06 Sep 2023 | Others | ₹13.75 Lakh | Open |
| 20 Jul 2023 | Axis Bank Limited | ₹1.4 Cr | Satisfied |
| 13 Dec 2019 | Others | ₹2 Cr | Satisfied |
| 16 Jun 2016 | Others | ₹80 Lakh | Satisfied |
Total charge records: 6 View all charges
Legal Cases of Nidus Pharma Private Limited
Nidus Pharma Private Limited has 3 court cases on record: 3 filed by Nidus Pharma. 1 case is pending and 2 are disposed. Status as checked between 28 Sep 2026 and 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ganganagar, Rajasthan | Criminal case | Filed by the company against an individual | Pending |
| District court, Ganganagar, Rajasthan | Court case (Complaint) | Filed by the company against Firm M/S Shree Budati Medical Store | Disposed |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against A.M. Enterprises | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Nidus Pharma Private Limited
Nidus Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 8 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Clitics India | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Mehar Laboratories | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Nidus Pharma Private Limited
Nidus Pharma Private Limited has a workforce of 5 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Nidus Pharma Private Limited
Nidus Pharma has one previous CIN (Corporate Identification Number): U24239DL2004PTC126061. The current CIN is U24239CH2004PTC041578, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239CH2004PTC041578 | Current |
| U24239DL2004PTC126061 | Previous |
Recent Activity on Nidus Pharma Private Limited
Nidus Pharma Private Limited has 10 board changes on record since 2004: 7 appointments and 3 cessations. The latest: Ankit Bansal ceased to be Director on 06 Oct 2025.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nidus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nidus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nidus Pharma Private Limited
Nidus Pharma has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCN9364Q1ZU | Chandigarh | Active | 05 Jun 2018 |
| 08AABCN9364Q1ZM | Rajasthan | Active | 01 Jul 2017 |
| 24AABCN9364Q1ZS | Gujarat | Active | 28 Nov 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nidus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nidus Pharma Private Limited
Nidus Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 April 2004 (22+ years old) and is registered under CIN U24239CH2004PTC041578.
Nidus Pharma reported revenue of ₹13.5 Cr for FY 2024 (up 49% YoY).
Nidus Pharma has 4 current directors:
- Sanjay Bansal - Director
- Alka Bansal - Director
- Prakhar Bansal - Director
- Krati Bansal - Director
Nidus Pharma reported a net profit of ₹37.36 Lakh (net margin 2.8%) and EBITDA of ₹68.24 Lakh (EBITDA margin 5.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nidus Pharma is 31% over three years and 18% over five years. In the latest year (FY 2024) revenue rose 49%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nidus Pharma is 04AABCN9364Q1ZU, registered in Chandigarh. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 08AABCN9364Q1ZM (Rajasthan), 24AABCN9364Q1ZS (Gujarat).
The CIN (Corporate Identification Number) of Nidus Pharma is U24239CH2004PTC041578. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nidus Pharma has 3 court cases on record: 3 filed by the company. 1 is pending.
Nidus Pharma was incorporated on 26 April 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Nidus Pharma by revenue are Rouzel Pharma Private Limited, Caplet Health Care Private Limited, Menrik Biomerge Private Limited, Dhwanilife Care Private Limited, Avancer Labs Private Limited and 5 more, all in the Pharma industry (Formulations).
Ankit Bansal ceased to be Director on 06 Oct 2025. Alka Bansal was appointed as Director on 03 Oct 2025. Krati Bansal was appointed as Director on 03 Oct 2025. Nidus Pharma has 10 board changes on record in total.
Nidus Pharma has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 8 overdue payments to 4 micro and small suppliers. The latest return was filed on 02 Dec 2019.